Literature DB >> 10840051

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes.

S B Wilson1, S C Kent, H F Horton, A A Hill, P L Bollyky, D A Hafler, J L Strominger, M C Byrne.   

Abstract

Quantitative and qualitative defects in CD1d-restricted T cells have been demonstrated in human and murine autoimmune diseases. To investigate the transcriptional consequences of T cell receptor activation in human Valpha24JalphaQ T cell clones, DNA microarrays were used to quantitate changes in mRNA levels after anti-CD3 stimulation of clones derived from identical twins discordant for type 1 diabetes and IL-4 secretion. Activation resulted in significant modulation of 226 transcripts in the IL-4 secreting clone and 86 in the IL-4-null clone. Only 28 of these genes were in common. The differences observed suggest both ineffective differentiation of diabetic Valpha24JalphaQ T cells and a role for invariant T cells in the recruitment and activation of cells from the myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840051      PMCID: PMC16559          DOI: 10.1073/pnas.120161297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.

Authors:  S K Mendiratta; W D Martin; S Hong; A Boesteanu; S Joyce; L Van Kaer
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

Review 2.  T-cell subsets: transcriptional control in the Th1/Th2 decision.

Authors:  M Rincón; R A Flavell
Journal:  Curr Biol       Date:  1997-11-01       Impact factor: 10.834

3.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 4.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production.

Authors:  F J Dumont; M J Staruch; P Fischer; C DaSilva; R Camacho
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

6.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

7.  Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase.

Authors:  A August; A Sadra; B Dupont; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

8.  T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells.

Authors:  K Q Liu; S C Bunnell; C B Gurniak; L J Berg
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

9.  Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.

Authors:  M Exley; J Garcia; S P Balk; S Porcelli
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

10.  alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

Authors:  K J Hammond; L D Poulton; L J Palmisano; P A Silveira; D I Godfrey; A G Baxter
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

View more
  26 in total

1.  Natural T cells: cranking up the immune system by prompt cytokine secretion.

Authors:  S Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.

Authors:  Silke Gillessen; Yuri N Naumov; Edward E S Nieuwenhuis; Mark A Exley; Frederick S Lee; Nicolas Mach; Andrew D Luster; Richard S Blumberg; Masaru Taniguchi; Steven P Balk; Jack L Strominger; Glenn Dranoff; S Brian Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

4.  CD1d and invariant NKT cells at the human maternal-fetal interface.

Authors:  Jonathan E Boyson; Basya Rybalov; Louise A Koopman; Mark Exley; Steven P Balk; Frederick K Racke; Frederick Schatz; Rachel Masch; S Brian Wilson; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

Review 5.  Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

6.  CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12.

Authors:  Simon C Yue; Angela Shaulov; Ruojie Wang; Steven P Balk; Mark A Exley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-09       Impact factor: 11.205

7.  Deficiency of 6B11+ invariant NK T-cells in celiac disease.

Authors:  Randall H Grose; Fiona M Thompson; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

Review 8.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

9.  Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands.

Authors:  Subramanya Hegde; Jennifer L Lockridge; Yusof A Becker; Shidong Ma; Shannon C Kenney; Jenny E Gumperz
Journal:  J Autoimmun       Date:  2011-04-12       Impact factor: 7.094

10.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.